Thursday, 21 May 2015

Bluebird's gene therapy continues to show promise in early study

(Reuters) - Biotech firm Bluebird Bio Inc said its experimental gene therapy continued to exhibit a positive effect in an ongoing early-stage study of patients with rare types of blood disorders.






No comments:

Post a Comment